Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss

NCT00844480 is registered in ClinicalTrials.gov with Thomas J. Schnitzer as lead sponsor.

NCT NCT00844480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00844480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss
Lead sponsor
Thomas J. Schnitzer
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2010
Completion date
January 31, 2016
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone loss